Knisely A, Dai Y, Barlow GL, Lee S, et al. Surgical and blood-based minimal residual disease in patients with ovarian cancer after frontline therapy: Clinical outcomes and translational opportunities. Clin Cancer Res 2025 Aug 1. doi: 10.1158/1078-0432.CCR-25-0512.
PMID: 40748258